181 related articles for article (PubMed ID: 33665137)
1. Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report.
Fassett MJ; Hernandez Lopez AL
Case Rep Womens Health; 2021 Apr; 30():e00294. PubMed ID: 33665137
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation.
Alashkar F; Saner FH; Vance C; Schmücker U; Herich-Terhürne D; Dührsen U; Köninger A; Röth A
Front Med (Lausanne); 2020; 7():543372. PubMed ID: 33102497
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
Miyasaka N; Miura O; Kawaguchi T; Arima N; Morishita E; Usuki K; Morita Y; Nishiwaki K; Ninomiya H; Gotoh A; Imashuku S; Urabe A; Shichishima T; Nishimura J; Kanakura Y
Int J Hematol; 2016 Jun; 103(6):703-12. PubMed ID: 26857155
[TBL] [Abstract][Full Text] [Related]
4. Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis.
Sharma R; Keyzner A; Liu J; Bradley T; Allen SL
Leuk Res Rep; 2015; 4(1):36-8. PubMed ID: 26052501
[TBL] [Abstract][Full Text] [Related]
5. A case report of pegcetacoplan use for a pregnant woman with paroxysmal nocturnal hemoglobinuria.
Du W; Mei L
Res Pract Thromb Haemost; 2024 May; 8(4):102435. PubMed ID: 38846741
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
[TBL] [Abstract][Full Text] [Related]
7. Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria.
Al-Jafar HA; AlDallal SM; Askar HA; Aljeraiwi AM; Al-Alansari A
Hematol Rep; 2015 Sep; 7(3):5927. PubMed ID: 26487933
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Case Series with Review of the Literature.
Al-Dosari YM; Al-Zahrani H; Al-Mohareb F; Hashmi S
Saudi J Med Med Sci; 2021; 9(2):178-189. PubMed ID: 34084110
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
Kelly RJ; Höchsmann B; Szer J; Kulasekararaj A; de Guibert S; Röth A; Weitz IC; Armstrong E; Risitano AM; Patriquin CJ; Terriou L; Muus P; Hill A; Turner MP; Schrezenmeier H; Peffault de Latour R
N Engl J Med; 2015 Sep; 373(11):1032-9. PubMed ID: 26352814
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.
Martí-Carvajal AJ; Anand V; Cardona AF; Solà I
Cochrane Database Syst Rev; 2014 Oct; (10):CD010340. PubMed ID: 25356860
[TBL] [Abstract][Full Text] [Related]
11. A patient with paroxysmal nocturnal hemoglobinuria being treated with eculizumab who underwent laparoscopic cholecystectomy: report of a case.
Moriyama M; Nagata T; Yoshioka I; Hashimoto I; Matsui K; Okumura T; Tsukada K
Surg Case Rep; 2015; 1(1):57. PubMed ID: 26366354
[TBL] [Abstract][Full Text] [Related]
12. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab].
Nishimura JI
Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704
[TBL] [Abstract][Full Text] [Related]
13. [Successful pregnancy and delivery achieved with eculizumab administration initiated after a preceding missed abortion in a patient with paroxysmal nocturnal hemoglobinuria].
Tsutsui M; Gotoh A; Komatsu N
Rinsho Ketsueki; 2019; 60(4):281-285. PubMed ID: 31068556
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report.
Alexopoulou A; Mani I; Tiniakos DG; Kontopidou F; Tsironi I; Noutsou M; Pantelidaki H; Dourakis SP
World J Hepatol; 2019 May; 11(5):483-488. PubMed ID: 31183008
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.
Karadag FK; Yenerel MN; Yılmaz M; Uskudar H; Ozkocaman V; Tuglular TF; Erdem F; Unal A; Ayyildiz O; Ozet G; Comert M; Kaya E; Ayer M; Salim O; Guvenc B; Ozdogu H; Mehtap Ö; Sonmez M; Guler N; Hacioglu S; Aydogdu İ; Bektas O; Toprak SK; Kaynar L; Yagci M; Aksu S; Tombak A; Karakus V; Yavasoglu İ; Onec B; Ozcan MA; Undar L; Ali R; Ilhan O; Saydam G; Sahin F
Am J Blood Res; 2021; 11(3):279-285. PubMed ID: 34322292
[TBL] [Abstract][Full Text] [Related]
16. Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab.
Tomazos I; Sierra JR; Johnston KM; Cheung A; Brodsky RA; Weitz IC
Hematology; 2020 Dec; 25(1):327-334. PubMed ID: 32856539
[No Abstract] [Full Text] [Related]
17. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria.
Göker H; Uz B; Büyükaşık Y; Aksu S; Haznedaroğlu İ; Sayınalp N; Karacan Y; Tekin F; Özcebe Oİ
Turk J Haematol; 2011 Sep; 28(3):223-7. PubMed ID: 27264371
[TBL] [Abstract][Full Text] [Related]
18. Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria.
Zareba KM
Drugs Today (Barc); 2007 Aug; 43(8):539-46. PubMed ID: 17925885
[TBL] [Abstract][Full Text] [Related]
19. Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones.
Mei M; Gupta R; O'Donnell M; Al Malki MM; Aldoss I; Ali H; Farol L; Snyder D; Forman SJ; Nakamura R; Khaled S
Biol Blood Marrow Transplant; 2019 May; 25(5):e183-e185. PubMed ID: 30708188
[TBL] [Abstract][Full Text] [Related]
20. [Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life].
Vinogradova MA; Kulagin AD; Shmakov RG
Ter Arkh; 2022 Aug; 94(7):859-864. PubMed ID: 36286943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
